Services

(Update September 2010) 

Assay

Primary screening

(Bath/Sample)

IC50 / MIC

(Bath/Sample)

Cytotoxicity against cancerous cell lines 

  • KB (human, oral cavity, carcinoma)
  • MCF-7 (human, breast, adenocarcinoma)
  • NCI-H187 (human, small cell lung, carcinoma)
  • HL-60 (human, leukemia)
  • HepG2 (human, liver, hepatocarcinoma,)
  • Caco-2 (human, colon, adenocarcinoma)
  • B16-F10 (mouse, skin, melanoma)
 
 
200
200
200
350
-
-
-
  
 
600
600
600
1000
2500 **
2500 **
2500 **

Cytotoxicity against normal cell lines

  • Vero (african green monkey, kidney, fibroblast)
  • HEp-2 (human, larynx, epithelial)
  • L929 (mouse, subcutaneous, connective tissue)
  • 3T3 (mouse, embryonic, fibroblast)
  • IEC6 (rat, small intestine, epithelial)
  • BHK(21)C(13) (baby hamster, kidney, fibroblast)
  • Human dermal skin fibroblast
  
 
300
 -
-
-
-
-
 -
 
  
900 
2500 **
2500 **
2500 **
2500 **
 2500 ** 
2500 **

Cytotoxicity against insect cell lines 

  • Sf9 (Spodopthera frugiperda, pupal ovarian tissue)
  • C6/36 (Aedes albopictus, mosquito larvae

 

-
-
 
 
2500 ** 
2500 **

Anti-human infectious pathogens

  • Anti-malaria (Plasmodium falciparum)
  • Anti-TB (Mycobacterium tuberculosis)
  • Anti-herpes simplex  virus type 1
  • Anti-fungal (Candida albicans)
  • Anti-bacteria (Bacillus cereus)
 
 
-
300
400
200
400
  
 
750
1000
1400
600
850
 

 Anti-plant disease pathogens 

  • Anti- blast disease (Magnaportha grisea)
  • Anti- dirty panicle disease (Curvularia lunata)
 
 
400
400
 
 
850
850

Neuraminidase inhibition assay (Avian influenza,H5N1)

450

700

Mycoplasma contamination test

1000

-

* IC50 = Inhibitory concentration at 50 % inhibition, MIC =Minimum inhibitory concentration at 90% inhibition

** Report includes IC50 + S.D. from three independent experiments. The assay is suitable for specific purposes such as pre-launched commercial and cosmetic products

Last Updated (Wednesday, 18 April 2012 08:56)